Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001609351-18-000009)

Filing Details

Accession Number:: 0001609351-18-000009
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-01-22 19:03:04
Reporting Period:: 2017-12-08

Accepted Time:: 2018-01-22 19:03:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609351	Spark Therapeutics Inc.	ONCE	Biological Products, (No Disgnostic Substances) (2836)	462654405

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1691218	John Furey	3737 Market Street Suite 1300 Philadelphia PA 19104	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-08	18	$73.48	18	No	4	P	Indirect	By mother-in-law
Common Stock	Disposition	2017-12-11	18	$46.33	0	No	4	S	Indirect	By mother-in-law

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By mother-in-law
No	4	S	Indirect	By mother-in-law

Footnotes

Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.